Sanità 22 Giugno 2016 15:13

Lung cancer: women mortality increases in Europe

The lung cancer is responsible for the huge number of deaths in France. It is mostly linked to the tobacco addiction and it is the most dangerous for men and the second one for women, with respectively 21000 and 9500 deaths. However, the Eurostat highlights a fall of death rate for men and an increase […]

The lung cancer is responsible for the huge number of deaths in France. It is mostly linked to the tobacco addiction and it is the most dangerous for men and the second one for women, with respectively 21000 and 9500 deaths. However, the Eurostat highlights a fall of death rate for men and an increase for women in Europe. Within the framework of the third Project about cancer 2014-2019, the French National High Authority for Health has the goal of detecting the cancer in smokers at an early stage, to make the treatment more effective. But the present situation shows that: the disease is hardly detected at an early stage because of its rapid evolution; the available exam is not suitable; treatment possibilities are extremely tight, also at an early stage; people who could take advantage of this exam are hardly identifiable; the mortality reduction is not assured in the French context; there are too many risks and few reliable benefits. The French National High Authority for Health concludes by saying that it is necessary to carry on the researches on the treatment, the disease characteristics and the detecting technics. It is also important to intensify the battle against the tobacco addiction with measures that increase awareness in young people and smokers to stop smoking.

GLI ARTICOLI PIU’ LETTI
One Health

One Health, il premio “Ambassador” ad oltre cento professionisti della salute

Con la premiazione di 102 professionisti, tra medici di medicina generale, farmacisti e medici veterinari, e la diffusione del report conclusivo, volge al termine la prima edizione di “One Healt...
Advocacy e Associazioni

Nasce l’Intergruppo Parlamentare “Innovazione Sanitaria e Tutela del Paziente”

L’Intergruppo punta in particolare a sviluppare strategie di programmazione sanitaria che integrino tecnologie avanzate, quali l’intelligenza artificiale e dispositivi medici innovativi, e...
Advocacy e Associazioni

HIV, è ancora emergenza: “Scarsa informazione, pochi test e tanto stigma”

Medici, Associazioni e Istituzioni, a pochi giorni dalla Giornata mondiale contro l’Aids, tornano a parlare di HIV per ridefinire l’agenda delle priorità. Presentato “HIV. Le ...
Salute

Uno sguardo alle patologie rare: storie di EPN

L’EPN è una malattia rara ancora poco conosciuta. Serve più formazione in questo campo. Ne parliamo con Antonella Sau, Ospedale Spirito Santo di Pescara, Giorgia Battipaglia, Azien...